{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:46:50Z","timestamp":1761101210396},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T00:00:00Z","timestamp":1384214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00277-013-1942-7","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T10:45:27Z","timestamp":1384166727000},"page":"107-111","source":"Crossref","is-referenced-by-count":2,"title":["Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma"],"prefix":"10.1007","volume":"93","author":[{"given":"Natalia","family":"Tovar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Fern\u00e1ndez de Larrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan I.","family":"Ar\u00f3stegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma. Teresa","family":"Cibeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rosi\u00f1ol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Elena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Filella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Yag\u00fce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Blad\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,12]]},"reference":[{"key":"1942_CR1","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1200\/JCO.2008.17.9721","volume":"26","author":"JJ Lahuerta","year":"2008","unstructured":"Lahuerta JJ, Mateos MV, Mart\u00ednez-L\u00f3pez J et al (2008) Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival. J Clin Oncol 26:5775\u20135782","journal-title":"J Clin Oncol"},{"key":"1942_CR2","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1182\/blood-2009-08-238196","volume":"115","author":"J Blad\u00e9","year":"2010","unstructured":"Blad\u00e9 J, Rosi\u00f1ol L, Cibeira MT et al (2010) Hematopoietic stem cell transplantation for multiple myeloma beyond 2010. Blood 115:3655\u20133663","journal-title":"Blood"},{"key":"1942_CR3","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.V91.9.3518","volume":"91","author":"C Zent","year":"1998","unstructured":"Zent C, Wilson C, Tricot G et al (1998) Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood 91:3518\u20133523","journal-title":"Blood"},{"key":"1942_CR4","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1182\/blood-2009-06-224832","volume":"114","author":"CF Larrea de","year":"2009","unstructured":"de Larrea CF, Cibeira M, Elena M et al (2009) Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition. Blood 114:4954\u20134956","journal-title":"Blood"},{"key":"1942_CR5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1365-2141.1999.01233.x","volume":"104","author":"JE Guikema","year":"1999","unstructured":"Guikema JE, Vellenga E, Veeneman JM et al (1999) Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation. Br J Haematol 104:748\u2013754","journal-title":"Br J Haematol"},{"key":"1942_CR6","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00262-012-1220-x","volume":"61","author":"J Rahlff","year":"2012","unstructured":"Rahlff J, Trusch M, Haag F et al (2012) Antigen-specificity of oligoclonal abnormal protein bands in multiple myeloma after allogenic stem cell transplantation. Cancer Immunol Immunother 61:1639\u20131651","journal-title":"Cancer Immunol Immunother"},{"key":"1942_CR7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blad\u00e9","year":"1998","unstructured":"Blad\u00e9 J, Samson D, Reece D et al (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation.Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 102:1115\u20131123","journal-title":"Br J Haematol"},{"key":"1942_CR8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2009.04.026","volume":"207","author":"R Businaro","year":"2009","unstructured":"Businaro R, Profumo E, Tagliani A et al (2009) Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 207:74\u201383","journal-title":"Atherosclerosis"},{"key":"1942_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/ard.58.5.291","volume":"58","author":"G Hayem","year":"1999","unstructured":"Hayem G, Bandt M, Palazzo E et al (1999) Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis 58:291\u2013296","journal-title":"Ann Rheum Dis"},{"key":"1942_CR10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0092-8674(00)80928-9","volume":"92","author":"B Bukau","year":"1998","unstructured":"Bukau B, Horwich A (1998) The Hsp70 and Hsp60 chaperone machines. Cell 92:351\u2013366","journal-title":"Cell"},{"key":"1942_CR11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2005.01.005","volume":"29","author":"TA Mehta","year":"2005","unstructured":"Mehta TA, Greenman J, Ettelaie C et al (2005) Heat shock proteins in vascular disease\u2014a review. Eur J Vasc Endovasc Surg 29:395\u2013402","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1942_CR12","first-page":"274","volume":"1","author":"MF Tsan","year":"2004","unstructured":"Tsan MF, Gao B (2004) Heat shock protein and innate immunity. Cell Mol Immunol 1:274\u2013279","journal-title":"Cell Mol Immunol"},{"key":"1942_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1054\/bjoc.1999.0881","volume":"82","author":"K Trieb","year":"2000","unstructured":"Trieb K, Gerth R, Holzer G et al (2000) Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy. Br J Cancer 82:85\u201387","journal-title":"Br J Cancer"},{"key":"1942_CR14","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2005-03-1158","volume":"107","author":"N Mitsiades","year":"2006","unstructured":"Mitsiades N, Mitsiades C, Poulaki V et al (2006) Antimyeloma activity of heat shock protein-90 inhibition. Blood 107:1092\u20131100","journal-title":"Blood"},{"key":"1942_CR15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3324\/haematol.2012.066175","volume":"98","author":"M Chatterjee","year":"2013","unstructured":"Chatterjee M, Andrulis M, St\u00fchmer T et al (2013) The PI3K\/Akt signalling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma. Haematologica 98:1132\u20131141","journal-title":"Haematologica"},{"key":"1942_CR16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0609.2010.01558.x","volume":"86","author":"A Allegra","year":"2011","unstructured":"Allegra A, Sant Antonio E, Penna G et al (2011) Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors. Eur J Haematol 86:93\u2013110","journal-title":"Eur J Haematol"},{"key":"1942_CR17","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2006-11-053728","volume":"110","author":"E Davenport","year":"2007","unstructured":"Davenport E, Moore H, Dunlop A et al (2007) Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells. Blood 110:2641\u20132649","journal-title":"Blood"},{"key":"1942_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2013.07.023","volume":"339","author":"L Zhang","year":"2013","unstructured":"Zhang L, Fok J, Mirabella F et al (2013) Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stress. Cancer Lett 339:49\u201359","journal-title":"Cancer Lett"},{"key":"1942_CR19","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1038\/sj.onc.1207114","volume":"22","author":"S Takayama","year":"2003","unstructured":"Takayama S, Reed JC, Homma S (2003) Heat-shock proteins as regulators of apoptosis. Oncogene 22:9041\u20139047","journal-title":"Oncogene"},{"key":"1942_CR20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","volume":"5","author":"L Whitesell","year":"2005","unstructured":"Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761\u2013772","journal-title":"Nat Rev Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1942-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1942-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1942-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T18:06:47Z","timestamp":1596823607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1942-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1942"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1942-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,12]]}}}